Imaging prognostication and tumor biology in hepatocellular carcinoma
- Author:
Diana KADI
1
;
Marilyn F. YAMAMOTO
;
Emily C. LERNER
;
Hanyu JIANG
;
Kathryn J. FOWLER
;
Mustafa R. BASHIR
Author Information
- Publication Type:Review Article
- From:Journal of Liver Cancer 2023;23(2):284-299
- CountryRepublic of Korea
- Language:English
- Abstract: Hepatocellular carcinoma (HCC) is the most common primary liver malignancy, and represents a significant global health burden with rising incidence rates, despite a more thorough understanding of the etiology and biology of HCC, as well as advancements in diagnosis and treatment modalities. According to emerging evidence, imaging features related to tumor aggressiveness can offer relevant prognostic information, hence validation of imaging prognostic features may allow for better noninvasive outcomes prediction and inform the selection of tailored therapies, ultimately improving survival outcomes for patients with HCC.
